MOM

Miraculins Inc. (TSX VENTURE:MOM) (the "Company"), a medical diagnostic company
focused on acquiring, developing and commercializing diagnostic tests and risk
assessment technologies for unmet clinical needs, announces today that David
Eichler has stepped down from the Company's Board of Directors. 


"The Board wishes to thank David for his effective contributions during his
tenure as a director," said Harry Bloomfield Q.C., Chair of the Miraculins
Board. 


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. 


FOR FURTHER INFORMATION PLEASE CONTACT: 
Miraculins Inc.
Christopher J. Moreau
President & CEO
204-477-7599
204-453-1546 (FAX)
info@miraculins.com
www.miraculins.com

Miraculins Inc. (TSXV:MOM)
過去 株価チャート
から 5 2024 まで 6 2024

Miraculins Inc. (TSXV:MOM)
過去 株価チャート
から 6 2023 まで 6 2024